key: cord-0788874-a1cv4n8y authors: Sarahian, Nahid; Saei Ghare Naz, Marzieh; Ramezani Tehrani, Fahimeh title: Following SARS-CoV-2 in the first trimester of pregnancy, what should we do in the 2nd, 3rd trimesters, and postpartum in terms of thyroid assessment? date: 2021-03-15 journal: Endocrine DOI: 10.1007/s12020-021-02678-1 sha: 9927e21b11c67ba97970a514ab658f5cd9bdbebf doc_id: 788874 cord_uid: a1cv4n8y nan There are a limited number of studies that investigated thyroid dysfunction in pregnant women after the COVID-19 pandemic [17, 18] . Cases of COVID-19-related hypothyroidism has been reported by two studies conducted in China in 3-4% of infected pregnant women [19, 20] . Recently, in a retrospective cohort study conducted in two groups of pregnant women including women who pregnant before COVID-19 outbreak, and those got pregnant during COVID-19 outbreak; they found that the recent group has significantly higher serum FT3, and lower FT4 levels compare to the other one [21] . It is assumed that COVID-19 per se may act as a trigger for thyroid abnormalities [4] [5] [6] 21] . In addition to the physiological changes of pregnancy, COVID-19 may also affect thyroid hormones through psychological pathways [22] [23] [24] . It is proposed that euthyroid pregnant women who infected by COVID-19 in the first trimester, may need to be re-assessed during 2nd, and 3rd trimesters and the postpartum periods. As a result in addition to the adverse effect of virus infection on pregnancy outcomes; this effect may be intensified by the possible impact of COVID-19 on the thyroid function of pregnant women [25, 26] . Given the more susceptibility of pregnant women to COVID-19 and the important role of thyroid hormones on pregnancy outcomes we recommended that: To re-assess the thyroid status of euthyroid pregnant women infected by COVID-19 in their 1st trimester of pregnancy, especially those who are considered as high risk for thyroid dysfunction or had a previous history of thyroid autoimmune disease. To re-assess the symptoms and signs of thyroid dysfunction in euthyroid pregnant women infected by COVID-19 in their 1st trimester of pregnancy. To provide a telehealth consultation plan for women who severely affected by COVID-19 during the first trimester of pregnancy for early diagnosis of thyroid dysfunction. To investigate the short and long-term obstetric and fetal outcomes in euthyroid women infected by COVID-19 in the first trimester of pregnancy and have thyroid dysfunction after infection. Conflict of interest The authors declare no competing interests. Ethical approval This article does not contain any studies with human participants or animals performed by any of the authors. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. With corona outbreak: nature started hitting the reset button globally. Fronti Endocrine and metabolic aspects of the COVID-19 pandemic Thyrotoxicosis in patients with COVID-19: the THYRCOV study Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series Subacute thyroiditis in COVID-19 patients SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19 Thyroid function before, during and after COVID-19 Thyroid function analysis in 50 patients with COVID-19: a retrospective study COVID-19, ACE2, and the cardiovascular consequences The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study Is pregnancy an immunological contributor to severe or controlled COVID-19 disease? Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening Is highly expressed ACE 2 in pregnant women "a curse" in times of COVID-19 pandemic? Immunological aspects of coronavirus disease during pregnancy: an integrative review Is pregnancy a risk factor of COVID-19? Why are pregnant women susceptible to COVID-19? An immunological viewpoint Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis COVID-19 in pregnant women and neonates: a systematic review of the literature with quality assessment of the studies Clinical manifestation and neonatal outcomes of pregnant patients with coronavirus disease 2019 pneumonia in Wuhan, China Coronavirus disease 2019 in pregnancy Thyroid hormone changes in early pregnancy along with the COVID-19 pandemic Thyroid function and postpartum mood disturbances in Greek women Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review Psychological impact of coronavirus disease 2019 in pregnant women Maternal immune responses and obstetrical outcomes of pregnantwomen with COVID-19 and possible health risks of offspring Impact ofCOVID-19 on maternal and neonatal outcomes: a systematic review and metaanalysis